AVEO Pharmaceuticals (AVEO:NASDAQ) Annual Reports & Investor Relations Material

Overview

AVEO Pharmaceuticals is a company that focuses on cancer therapeutics. Their goal is to discover, develop and sell targeted therapies that can make a difference for cancer patients. The company is committed to conducting research in order to offer innovative and effective treatments. They hope to improve the lives of people who are struggling with various types of cancer by providing them with the best possible treatment options.

Annual Reports

Frequently Asked Questions

What is AVEO Pharmaceuticals's ticker?

AVEO Pharmaceuticals's ticker is AVEO

What exchange is AVEO Pharmaceuticals traded on?

The company's shares trade on the NASDAQ stock exchange

Where are AVEO Pharmaceuticals's headquarters?

They are based in Boston, Massachusetts

How many employees does AVEO Pharmaceuticals have?

There are 51-200 employees working at AVEO Pharmaceuticals

What is AVEO Pharmaceuticals's website?

It is aveooncology.com

What type of sector is AVEO Pharmaceuticals?

AVEO Pharmaceuticals is in the Healthcare sector

What type of industry is AVEO Pharmaceuticals?

AVEO Pharmaceuticals is in the Biotechnology industry

Who are AVEO Pharmaceuticals's peers and competitors?

The following five companies are AVEO Pharmaceuticals's industry peers:

- Aeglea BioTherapeutics, Inc.

- Acer Therapeutics Inc.

- Affimed

- iBio

- Bio-Techne